Answer
In Ultibro Breezhaler, indacaterol activates beta2-adrenoceptors, acting partly through adenyl cyclase stimulation and increased cyclic AMP to relax bronchial smooth muscle, while glycopyrronium antagonises muscarinic receptors to block acetylcholine-mediated bronchoconstriction, providing additive effects through different pathways.
Sources for this answer
- Ultibro BreezhalerNovartis Pharmaceuticals UK Ltd · emc · SmPC §5.1 Pharmacodynamic properties · Version 11Document updated
Sources checked